Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients

Table 1

The baseline characteristics of patients.

Characteristics	Control group; (%)	Study group; (%)		value
Age (y)			0.029	0.866
≤65	39 (53%)	16 (52%)
>65	34	15
Gender (M/F)			0.006	0.937
Male	43 (59%)	18 (58%)
Female	30	13
BCLC staging			4.964	0.174
0	10	2
A	42 (58%)	14 (45%)
B	17	10
C	4	5
Conventional therapy			4.935	0.085
RFA	57 (78%)	24 (77%)
TACE	6	6
Surgery	10	1